Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited has recently updated the market on its ongoing stock buy-back program, indicating that an additional 10,000 ordinary fully paid shares were repurchased the previous day. This move is part of the company’s strategy to buy back shares, with a total of 5,419 acquired prior to the latest transaction. The announcement was made to keep shareholders informed of the company’s daily buy-back activities.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
